Action Interleukin Genetics - ILI

Interleukin Genetics, (ILI) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

( - )

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

WALTHAM, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will make a corporate...

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

WALTHAM, Mass. and MADRID, Jan. 19 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) and LABEC Pharma, S.L. announced today...

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Test Available Under Inherent Health(TM) Brand Promotes Early Action for Fracture Prevention with Recommendations for Improving Bone Health...

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

WALTHAM, Mass., Dec. 7 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it has received approval by the...

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

New Study Published in Annals of Rheumatic Diseases Suggests IL-1 Biology Plays Central Role in Development of Severe Knee Osteoarthritis WALTHAM...

Interleukin Genetics Reports Third Quarter 2009 Financial Results

WALTHAM, Mass., Nov. 12 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) today announced financial and operational results...

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will host a conference call...

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

WALTHAM, Mass. and ADA, Mich., Oct. 29 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it has entered into...

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

WALTHAM, Mass., Oct. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic...

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

Subjects on Diets Appropriate for their Genotype Achieved Statistically significant Average Weight Loss of 6.2% of Body Weight at one year...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

ILI - Frequently Asked Questions (FAQ)

What is the current Interleukin Genetics, share price?

The current share price of Interleukin Genetics, is US$ 0,00

What is the 1 year trading range for Interleukin Genetics, share price?

Interleukin Genetics, has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Interleukin Genetics, (ILI)

Interleukin Genetics, (ILI) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

ILI Dernières nouvelles

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

Interleukin Genetics Reports Third Quarter 2009 Financial Results

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

ILI - Frequently Asked Questions (FAQ)

ILI Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Interleukin Genetics, (ILI)

Interleukin Genetics, (ILI) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

ILI Dernières nouvelles

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

Interleukin Genetics Reports Third Quarter 2009 Financial Results

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

ILI - Frequently Asked Questions (FAQ)

ILI Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE